logo







Home>Companies>Fusion-pharmaceuticals-nas-fusn


Fusion pharmaceuticals (nas: fusn)

Fusion pharmaceuticals (nas: fusn)



Fusion Pharmaceuticals (NAS: FUSN) is a biopharmaceutical company specializing in the development of targeted alpha therapies aimed at treating various types of cancer.
Sign up today to get real-time market insights on Fusion pharmaceuticals (nas: fusn) and hundreds of other pre-IPO companies



Fusion pharmaceuticals (nas: fusn) Overview

2014
Biotech
https://www.fusionpharma.com



Fusion pharmaceuticals (nas: fusn) Live Market Data

$00000000
$00000000




Fusion pharmaceuticals (nas: fusn) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO6/26/2020
Series B3/25/2019
Early Stage VC9/25/2017
Seed Round1/9/2016




Fusion pharmaceuticals (nas: fusn) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Adams Street PartnersSeries B, Early Stage VCSeries B (2019-03-25)
TPG (NAS: TPG)Series B, Early Stage VCSeries B (2019-03-25)
CPP InvestmentsSeries BSeries B (2019-03-25)




Fusion pharmaceuticals (nas: fusn) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Fusion pharmaceuticals (nas: fusn) data




Fusion pharmaceuticals (nas: fusn) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Fusion pharmaceuticals (nas: fusn) data




Latest Fusion pharmaceuticals (nas: fusn) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.